Lindsey Compton, | |
4038 Old Munfordville Rd, Cave City, KY 42127-9392 | |
(270) 528-1911 | |
Not Available |
Full Name | Lindsey Compton |
---|---|
Gender | Female |
Speciality | Speech-language Pathologist |
Location | 4038 Old Munfordville Rd, Cave City, Kentucky |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1548671985 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
235Z00000X | Speech-language Pathologist | 23559 (Kentucky) | Primary |
Mailing Address | Practice Location Address |
---|---|
Lindsey Compton, 4038 Old Munfordville Rd, Cave City, KY 42127-9392 Ph: () - | Lindsey Compton, 4038 Old Munfordville Rd, Cave City, KY 42127-9392 Ph: (270) 528-1911 |
News Archive
Dr Jianguang Ji, Lund University, and Skåne University Hospital, Malmö, Sweden, and colleagues investigated data from the Swedish Cancer Registry. Researchers analyzed Swedish hospital data from 1969 to 2008. They found 1,510 patients with Huntington's disease. During the study period, 91 of those patients subsequently developed cancer. The authors said that was 53% lower than the levels expected for the general population.
Stereotaxis, Inc. announced today that the underwriters for the recently announced public offering of Stereotaxis common stock have exercised in full their over-allotment option to purchase an additional 975,000 shares of the Company's common stock. The 7,475,000 shares of Stereotaxis common stock in the offering, including the 975,000 shares subject to the over-allotment option, are being sold at a price to the public of $4.00 per share.
After years of studying the effects of near-infrared light on veterans with post-traumatic stress disorder or traumatic brain injuries, a team led by a University of Texas at Arlington bioengineer has published groundbreaking research in Nature's Scientific Reports that could result in an effective, long-term treatment for brain disorders.
Two studies in today's Nature Neuroscience, led by researchers at Boston Children's Hospital, Brigham and Women's Hospital (BWH), and Harvard Medical School (HMS), implicate mosaic mutations arising during embryonic development as a cause of autism spectrum disorder (ASD). The findings open new areas for exploring the genetics of ASD and could eventually inform diagnostic testing.
› Verified 5 days ago
Karissa Gwen Newberry, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 6877 Happy Valley Rd, Cave City, KY 42127 Phone: 270-773-2929 |